The company’s revenue rose to above $100 billion in the quarter for the first time and profit soared 86 percent.
Category: Prices (Fares, Fees and Rates)
-
Candy Companies Are Quietly Cutting Down on Cocoa to Save Money
As climate change has helped push cocoa prices higher, companies are changing candy recipes in subtle ways.
-
F.D.A. Moves to Speed Approvals for Cheaper Copycat Drugs
The agency announced moves to cut regulatory obstacles for the makers of biosimilar drugs, which are akin to generics and may help lower drug costs.
-
Obamacare Prices Become Public, Highlighting Big Increases
The government website now shows consumers how much their health insurance costs will increase next year, as Congress remains at an impasse over the plans’ subsidies.
-
Boeing Reports Bigger Quarterly Loss but Sales Improved
The aerospace company was hurt by the delay of a new plane but made progress on increasing production of the 737 Max, its most popular aircraft.
-
Trump Administration Backs Plan for New Nuclear Plants
The federal government announced that it would back an effort to build several Westinghouse nuclear reactors, but offered few details.
-
Companies Have Shielded Buyers From Tariffs. But Not for Long.
Cars, toys and tea are among products set to get more expensive as tariffs weigh on corporate profits.
-
2025 Halloween Candy Trends
This year’s Halloween candy sales suggest that Americans are feeling divided, strapped and in need of a (mild) surprise or two.
-
Ford’s Profit Jumps on Strong Sales but Company Lowers its Outlook
Ford said a fire at an aluminum factory will lower profits in the last three months of the year. The company also said it has stopped making an electric version of its popular F-150 pickup.
-
Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices
In a first, Colorado will cap the price of Enbrel, an arthritis drug. Using patent tactics, the drugmaker Amgen has aggressively blocked competition for it.